Visudyne
Product Images NDC 50236-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Visudyne (NDC 50236-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qlt Ophthalmics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Verteporfin Regioisomer Structures (41e7889e A183 4fea 9e12 63052f878cc0 01)

Chemical structures showing two related molecules labeled with ring letters A, B, C, and D. These represent components of the active ingredient associated with Visudyne, a product by QLT Ophthalmics, Inc. The structures include multiple rings, double bonds, and functional groups such as methoxy and carboxyl groups.*

FDA Label Image

Visudyne Carton (not To Scale) (41e7889e A183 4fea 9e12 63052f878cc0 02)

Packaging label for Visudyne 15 mg (verteporfin for injection) by QLT Ophthalmics, Inc. The label displays the product name, active ingredient, strength, and dosage form, along with the NDC 50236-001-15. It includes instructions indicating it is for injection and prescription use only with manufacturer and distributor information. The label features the QLT Ophthalmics logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.